335 related articles for article (PubMed ID: 21123390)
1. Impact of valency of a glycoprotein B-specific monoclonal antibody on neutralization of herpes simplex virus.
Krawczyk A; Krauss J; Eis-Hübinger AM; Däumer MP; Schwarzenbacher R; Dittmer U; Schneweis KE; Jäger D; Roggendorf M; Arndt MA
J Virol; 2011 Feb; 85(4):1793-803. PubMed ID: 21123390
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of the epitope for a herpes simplex virus glycoprotein B-specific monoclonal antibody with high protective capacity.
Däumer MP; Schneider B; Giesen DM; Aziz S; Kaiser R; Kupfer B; Schneweis KE; Schneider-Mergener J; Reineke U; Matz B; Eis-Hübinger AM
Med Microbiol Immunol; 2011 May; 200(2):85-97. PubMed ID: 20931340
[TBL] [Abstract][Full Text] [Related]
3. Glycoprotein C of Herpes Simplex Virus 1 Shields Glycoprotein B from Antibody Neutralization.
Komala Sari T; Gianopulos KA; Nicola AV
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826995
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B.
Cairns TM; Fontana J; Huang ZY; Whitbeck JC; Atanasiu D; Rao S; Shelly SS; Lou H; Ponce de Leon M; Steven AC; Eisenberg RJ; Cohen GH
J Virol; 2014 Mar; 88(5):2677-89. PubMed ID: 24352457
[TBL] [Abstract][Full Text] [Related]
5. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
Du R; Wang L; Xu H; Wang Z; Zhang T; Wang M; Ning Y; Deng F; Hu Z; Wang H; Li Y
Antiviral Res; 2017 Nov; 147():131-141. PubMed ID: 29061442
[TBL] [Abstract][Full Text] [Related]
6. Patient-Specific Neutralizing Antibody Responses to Herpes Simplex Virus Are Attributed to Epitopes on gD, gB, or Both and Can Be Type Specific.
Cairns TM; Huang ZY; Gallagher JR; Lin Y; Lou H; Whitbeck JC; Wald A; Cohen GH; Eisenberg RJ
J Virol; 2015 Sep; 89(18):9213-31. PubMed ID: 26109729
[TBL] [Abstract][Full Text] [Related]
7. The Fusion Loops of the Initial Prefusion Conformation of Herpes Simplex Virus 1 Fusion Protein Point Toward the Membrane.
Fontana J; Atanasiu D; Saw WT; Gallagher JR; Cox RG; Whitbeck JC; Brown LM; Eisenberg RJ; Cohen GH
mBio; 2017 Aug; 8(4):. PubMed ID: 28830949
[TBL] [Abstract][Full Text] [Related]
8. Structural basis for the antibody neutralization of herpes simplex virus.
Lee CC; Lin LL; Chan WE; Ko TP; Lai JS; Wang AH
Acta Crystallogr D Biol Crystallogr; 2013 Oct; 69(Pt 10):1935-45. PubMed ID: 24100313
[TBL] [Abstract][Full Text] [Related]
9. Cell-to-Cell Spread Blocking Activity Is Extremely Limited in the Sera of Herpes Simplex Virus 1 (HSV-1)- and HSV-2-Infected Subjects.
Criscuolo E; Castelli M; Diotti RA; Amato V; Burioni R; Clementi M; Ambrosi A; Mancini N; Clementi N
J Virol; 2019 Jun; 93(11):. PubMed ID: 30867302
[TBL] [Abstract][Full Text] [Related]
10. Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus.
Seyfizadeh N; Kalbermatter D; Imhof T; Ries M; Müller C; Jenner L; Blumenschein E; Yendrzheyevskiy A; Grün F; Moog K; Eckert D; Engel R; Diebolder P; Chami M; Krauss J; Schaller T; Arndt M
J Biomed Sci; 2024 May; 31(1):56. PubMed ID: 38807208
[TBL] [Abstract][Full Text] [Related]
11. Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.
Hook LM; Cairns TM; Awasthi S; Brooks BD; Ditto NT; Eisenberg RJ; Cohen GH; Friedman HM
PLoS Pathog; 2018 May; 14(5):e1007095. PubMed ID: 29791513
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal antibodies in the diagnosis of infections caused by the herpes simplex virus].
Klimova RR; Masalova OV; Atanadze SN; Kushch AA
Zh Mikrobiol Epidemiol Immunobiol; 1999; (5):99-103. PubMed ID: 10852033
[TBL] [Abstract][Full Text] [Related]
13. Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine.
Awasthi S; Belshe RB; Friedman HM
J Infect Dis; 2014 Aug; 210(4):571-5. PubMed ID: 24652496
[TBL] [Abstract][Full Text] [Related]
14. Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function.
Cairns TM; Shaner MS; Zuo Y; Ponce-de-Leon M; Baribaud I; Eisenberg RJ; Cohen GH; Whitbeck JC
J Virol; 2006 Mar; 80(6):2596-608. PubMed ID: 16501070
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus type 1-specific immunity induced by peptides corresponding to an antigenic site of glycoprotein B.
Mester JC; Highlander SL; Osmand AP; Glorioso JC; Rouse BT
J Virol; 1990 Nov; 64(11):5277-83. PubMed ID: 1698994
[TBL] [Abstract][Full Text] [Related]
16. Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes.
Awasthi S; Huang J; Shaw C; Friedman HM
J Virol; 2014 Aug; 88(15):8421-32. PubMed ID: 24829358
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection.
Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G
Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708
[TBL] [Abstract][Full Text] [Related]
18. Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions.
Bender FC; Samanta M; Heldwein EE; de Leon MP; Bilman E; Lou H; Whitbeck JC; Eisenberg RJ; Cohen GH
J Virol; 2007 Apr; 81(8):3827-41. PubMed ID: 17267495
[TBL] [Abstract][Full Text] [Related]
19. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E.
Hook LM; Huang J; Jiang M; Hodinka R; Friedman HM
J Virol; 2008 Jul; 82(14):6935-41. PubMed ID: 18480440
[TBL] [Abstract][Full Text] [Related]
20. Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity.
Roller DG; Dollery SJ; Doyle JL; Nicola AV
Virology; 2008 Dec; 382(2):207-16. PubMed ID: 18950828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
